Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
Phase 1
Active, not recruiting
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Sciwind Biosciences USA Co., Ltd.
- Target Recruit Count
- 152
- Registration Number
- NCT05579314
- Locations
- 🇺🇸
ICON - Early Development Services, Salt Lake City, Utah, United States
News
No news found